227. Osler disease
49 clinical trials,   69 drugs   (DrugBank: 21 drugs),   23 drug target genes,   132 drug target pathways

Searched query = "Osler disease", "Hereditary hemorrhagic telangiectasia", "Osler-Weber-Rendu disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00588146
(ClinicalTrials.gov)
January 200726/12/2007Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic TelangiectasiaPhase 2 Study of PEG-Intron in Hereditary Hemorrhagic TelangiectasiaAnemia;Liver Disease;HypoxemiaDrug: Pegylated Interferon Alpha2b;Other: Standard careMayo ClinicAugusta University;St. Michael's Hospital, Toronto;Schering-PloughTerminated18 Years70 YearsAll10Phase 2United States